The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 Mar 2020 07:00

RNS Number : 1202H
Electrocomponents PLC
23 March 2020
 

Electrocomponents plc today issues a pre-close trading update for the year ending 31 March 2020 and an update on COVID-19, ahead of reporting full-year results in May 2020.

COVID-19 update

As we closely monitor the impact of COVID-19, our priority is to safeguard the health and wellbeing of our employees and to continue to support our customers and suppliers across the globe. As we do so, we are adhering to advice from government health agencies including the World Health Organisation.

In January we formed a central crisis management team to manage our response to the outbreak in Asia Pacific and our experience there has meant that we have been able to quickly implement business continuity plans across the globe. These plans include:

· Monitoring inventory and our supply chain to ensure consistency of supply,

· Building continuity plans for our distribution centres, and

· Extensive home working for our office-based teams.

These plans are working well and the response of our people has been outstanding. At the present time, all our distribution centres around the world remain open and operating effectively, with the exception of our distribution centres in France and Italy. We are currently servicing our French and Italian customers out of the UK. Our online business model continues to differentiate us and has helped us maintain service levels to our customers which include critical industries such as the public sector, food and beverage, power generation and utilities. However, whilst we continue to be able to manage the supply side, there is now evidence that increasing restrictions in some of our major markets are impacting demand. 

Current trading

Up to and including the week ended 15 March 2020, the Group saw limited impact from COVID-19 on levels of customer demand.

· Group like-for-like(1) revenue growth in the 11-week period ended 15 March was c. 4%.

· All three regions saw positive like-for-like revenue growth across the period, with EMEA up 3%, Americas up 3% and Asia Pacific strongly up 11%.

While market conditions are changing rapidly and it is difficult to draw conclusions from a single week of trading, it is notable that in the week ended 22 March like-for-like Group revenue growth has slowed to a high single-digit decline. Revenue trends have worsened across the week and volume levels vary considerably between markets. Those markets where public mobility has been most restricted, such as Italy and France, are seeing the largest impact with volumes down significantly driven primarily by lower demand. Other markets, where restrictions are only just now being implemented, such as the UK and US, are seeing a more modest impact on revenue at this stage.

While we currently expect to deliver adjusted(2) PBT for the year ending 31 March 2020 around the bottom end of our current market consensus(3) range, it remains a rapidly evolving situation. It remains too early to assess the impact that the unfolding COVID-19 situation will have on trading in the year ending 31 March 2021.

Balance sheet and liquidity

We enter this period of uncertainty in a strong financial position with a cash generative business model.

· At 30 September 2019 net debt to adjusted EBITDA was 0.9 times and adjusted EBITA to interest was over 40 times.

· Our financial covenants are net debt to adjusted EBITDA < 3.25 times and adjusted EBITA to interest of > 3 times.

· Net debt on 29 February 2020 was £209 million (including £57 million of lease liabilities), down from £221 million at 30 September 2019.

· Current committed facilities amount to £380 million, with over £340 million of these facilities maturing beyond July 2022. As of 29 February 2020, c.£180 million of our facilities are undrawn.

Mitigating actions

In anticipation of lower demand levels in the short term we are acting now to protect profitability and to conserve cash, while seeking to ensure the Group is well placed to benefit when the recovery takes place. We are reviewing all discretionary expenditure, both operating and capital, and considering suitable government assistance programmes in the markets in which we operate to preserve the productive capacity of the business as far as possible.

We will continue to support the needs of all our customers, suppliers and employees through this challenging period. Electrocomponents is also assisting the fight against COVID-19 by supporting one of the UK manufacturing consortia as they seek to rapidly develop new medical ventilation equipment.

Overall

The Group's strong financial position, coupled with our differentiated online business model, global distribution network and strong supplier relationships, means that we remain well positioned to weather the present crisis and to continue driving growth and market share gains over the medium term.

LEI: 549300KVXDURRKVWR37

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Polly Elvin

Head of Investor Relations

020 7239 8427

Martin Robinson/ Lisa Jarrett-Kerr

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions, changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2019 is converted at 2020 average exchange rates for the period.  

2. Adjusted excludes amortisation of intangible assets arising on acquisition of businesses, substantial reorganisation costs, substantial asset write-downs, one-off pension credits or costs, significant tax rate changes and associated income tax.

3. The current consensus range for adjusted PBT for the year ending 31 March 2020 is £209.2 million to £216.0 million.

4. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2019 for euro and US$ respectively were €1.13 and $1.31 respectively. Every 1 cent movement in the euro has a circa £1.4 million impact on annual profit. Every 1 cent movement in the US $ has a circa £0.5 million impact on annual profit.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFSIVSIFFII
Date   Source Headline
13th Jul 20127:00 amRNSInterim Management Statement
4th Jul 20121:21 pmRNSDirector/PDMR Shareholding
4th Jul 20121:16 pmRNSDirector/PDMR Shareholding
2nd Jul 201211:28 amRNSTotal Voting Rights
2nd Jul 201211:25 amRNSHolding(s) in Company
21st Jun 20129:35 amRNSNotice of IMS
15th Jun 20122:37 pmRNSAnnual Information Update
8th Jun 201211:43 amRNSAnnual Financial Report
6th Jun 20123:33 pmRNSDirector/PDMR Shareholding
1st Jun 20124:25 pmRNSTotal Voting Rights
24th May 20127:00 amRNSFinal Results
23rd May 20122:17 pmRNSAdditional Listing
15th May 201210:13 amRNSHolding(s) in Company
1st May 20129:40 amRNSTotal Voting Rights
2nd Apr 201210:55 amRNSTotal Voting Rights
30th Mar 20127:00 amRNSTrading Statement
6th Mar 20129:36 amRNSNOTICE OF PRE-CLOSE TRADING UPDATE
29th Feb 201211:53 amRNSTotal Voting Rights
22nd Feb 201211:33 amRNSHolding(s) in Company
13th Feb 201211:00 amRNSAnalyst Briefing
3rd Feb 20127:00 amRNSInterim Management Statement
1st Feb 201212:20 pmRNSBlocklisting Interim Review
31st Jan 201210:20 amRNSTotal Voting Rights
11th Jan 201212:37 pmRNSVoting Rights and Capital - Correction
6th Jan 20129:30 amRNSNotice of IMS
3rd Jan 20129:49 amRNSTotal Voting Rights
6th Dec 201110:22 amRNSHolding(s) in Company
2nd Dec 201111:50 amRNSHolding(s) in Company
30th Nov 20111:51 pmRNSTotal Voting Rights
14th Nov 20117:00 amRNSHalf Yearly Report
31st Oct 20111:33 pmRNSTotal Voting Rights
7th Oct 20111:34 pmRNSStatement re Chairman
3rd Oct 20117:00 amRNSTrading Statement
30th Sep 20112:43 pmRNSTotal Voting Rights
28th Sep 20112:06 pmRNSHolding(s) in Company
15th Sep 201111:23 amRNSHolding(s) in Company
9th Sep 20111:38 pmRNSHolding(s) in Company
7th Sep 201112:43 pmRNSNotice of Trading Update
1st Sep 20117:00 amRNSTotal Voting Rights
31st Aug 20112:49 pmRNSAdditional Listing
26th Aug 20113:12 pmRNSHolding(s) in Company
18th Aug 20111:08 pmRNSHolding(s) in Company
4th Aug 20119:47 amRNSHolding(s) in Company
1st Aug 201111:04 amRNSBlocklisting Interim Review
1st Aug 201111:03 amRNSTotal Voting Rights
21st Jul 20112:03 pmRNSHolding(s) in Company
19th Jul 20119:29 amRNSHolding(s) in Company
18th Jul 20111:15 pmRNSDirector/PDMR Shareholding
15th Jul 20112:05 pmRNSResult of AGM
15th Jul 20117:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.